Factors identified for increased post-surgery weight gain among breast cancer survivors
the ONA take:
According to a new study published in the journal BMC Cancer, researchers have found that average long-term weight gain among breast cancer survivors is small, but certain subgroups of women experience greater weight gain associated with adverse health.
For the study, researchers sought to investigate body weight changes following breast cancer over 6 years and whether weight changes are linked with behavioral, diagnostic, personal, or treatment characteristics. Researchers identified 287 Australian women diagnosed with early-stage invasive breast cancer.
Results showed that 57% of women were overweight or obese at 6 months post-surgery, which increased to 68% at 72 months post-surgery. Researchers found that 24% of participants experienced clinically significant weight gain between 6 and 18 months and 39% experienced clinically significant weight gain between 6 and 72 months post-surgery.
In addition, researchers found that more extensive lymph node removal, receiving radiation therapy, being treated on the non-dominant side, and decreased physical activity levels at 6 months post-surgery were associated with higher body weights after breast cancer.
The findings suggest that healthy weight education should be integrated into breast cancer care to improve the quality of cancer survivorship.
Average long-term weight gain among breast cancer survivors is small, but certain subgroups experience greater gain associated with adverse health.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|